In a search for mechanisms underlying the increased cancer risk that is associated with the combination of metabolic deregulation and circadian disruption, Ramos et al. demonstrated that a non-canonical function of BMAL1 limits obesity-promoted triple-negative breast cancer [95]. The gene discussed is BMAL1; the disease is obesity due to melanocortin 4 receptor deficiency.